Ariane van der Straten
Director, Women’s Global Health Imperative
Ariane van der Straten is senior research scientist and director of the Women's Global Health Imperative within RTI, and associate professor at the University of California, San Francisco. Her major research interests are behavioral and biomedical interventions for prevention of heterosexual transmission of HIV in the U.S. and Africa. She focuses on female-initiated methods and adherence-related issues in the context of prevention trials, using quantitative and qualitative research methods. Dr. van der Straten has played a crucial role in the development and implementation of several major research projects, such as the Methods for Improving Reproductive Health in Africa trial. Currently, she is part of the protocol team for VOICE (a phase IIb trial of daily Tenofovir gel, oral Truvada, or Tenofovir tablets) and co-chair of a qualitative ancillary study to VOICE, focusing on the context of adherence to microbicides and pre-exposure prophylaxis (PrEP) in Africa.
MPH, Public Health, The Johns Hopkins University, School of Hygiene and Public Health; PhD, Zoology (summa cum laude), University of Brussels, Laboratory of Genetics; BS (summa cum laude), Zoology-Molecular Biology, University of Louvain, Belgium.
van der Straten, A., Montgomery, E.T., Hartmann, M., & Minnis, A. (Mar 2013)
McCoy, S.I., Zheng, W., Montgomery, E., Blanchard, K., van der Straten, A., de Bryn, G., et al. (Mar 2013)
van der Straten, A., Montgomery, E., Pillay, D., Cheng, H., Naidoo, A., Cele, Z., Naidoo, K., Hartmann, M., et al. (Feb 2013)
van der Straten, A., Cheng, H., Wasdo, S., Montgomery, L., Smith-McCune, K., Booth, M., et al. (Jan 2013)
Mensch, B.S., van der Straten, A., & Katzen, L.L. (Nov 2012)
- Female-Initiated HIV Prevention Methods: Microbicides, Barrier Methods, and PrEP
- Acceptability, Adherence, and Their Measurement
- Clinical Trials
- Qualitative and Quantitative Research Methods